It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

The start-up – founded by investment group Flagship Pioneering – said that OPL-0401 did not meet either the primary or ...

Building on the success of the anti-Myostatin program, iBio Launches New Program Featuring Myostatin + Activin A Bispecific ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a ...

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...

Veeda Group has unveiled a new logo and brand identity--Veeda Lifesciences--marking a key milestone in its journey. The new ...